Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07237295 · ClinicalTrials.gov registry record · NA
CommunityRx-Kidney Health
A NA study of Chronic Kidney Disease (Stages 1-4), sponsored by University of North Carolina, Chapel Hill.
- Recruiting
- Registry status
- NA
- Development phase
- 634
- Enrollment target
- 1
- Study location
NCT07237295: Recruiting NA study of Chronic Kidney Disease (Stages 1-4), sponsored by University of North Carolina, Chapel Hill.
NCT07237295 is a NA study of Chronic Kidney Disease (Stages 1-4) that is actively recruiting participants, run by University of North Carolina, Chapel Hill. The registered enrollment target is 634 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07237295, a NA study of Chronic Kidney Disease (Stages 1-4), is actively recruiting participants, sponsored by University of North Carolina, Chapel Hill.
- RECRUITING
- Registry status
- NA
- Development phase
- 634 participants
- Enrollment target
- 1
- Study location
Study Summary
In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care resources to improve CKD management in rural eastern North Carolina. Through a partnership among local primary care centers, community organizations, and researchers, CRx-K will strengthen rural care networks, improve CKD management, and enhance the well-being of rural communities.
Primary Outcome
Acute healthcare utilization is measured as the sum of self-reported 911 calls, ambulance visits, emergency room visits, urgent care visits, and hospital admissions across the 12-month follow-up period.
Conditions Studied
Interventions
- BEHAVIORAL CommunityRx-Kidney Health
Study Locations (1)
North Carolina
- Goshen Medical Center - Beulaville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 634 participants |
| Start Date | 2026-03 |
| Est. Completion | 2027-12 |
| Phase | NA |
What NCT07237295 shows while recruiting
NCT07237295 is an interventional study that assigns participants to a tested intervention. The registered 634 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (55% lower).
The record links to 1 condition, with Chronic Kidney Disease (Stages 1-4) appearing as the primary indexed condition, and to 1 intervention - of which CommunityRx-Kidney Health is the first listed.
NCT07237295 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT07237295 about?
NCT07237295 is a clinical study titled "CommunityRx-Kidney Health". In the United States, the burden of chronic kidney disease (CKD) rests disproportionately on rural communities. This study evaluates the implementation and effectiveness of CommunityRx-Kidney Health (CRx-K); this health information technology intervention integrates medical, social, and self-care re...
What is the current status of trial NCT07237295?
This trial is currently recruiting. It is a NA study. The enrollment target is 634 participants. The study started on 2026-03. Estimated completion is 2027-12.
What conditions does trial NCT07237295 study?
This clinical trial studies the following conditions: Chronic Kidney Disease (Stages 1-4).
What interventions are being tested in trial NCT07237295?
The interventions under investigation include: CommunityRx-Kidney Health (BEHAVIORAL).
Who is sponsoring clinical trial NCT07237295?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07237295 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07237295's enrollment target sits among peer trials
634 158th of 2000 higher than 1,843 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573027 · 634 participants · NA
Heart Disease of the Small Arteries in Women and Men
- NCT04108156 · 634 participants · Phase 3
A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
- NCT03478826 · 635 participants
Creation of a Biospecimen Repository From Patients With Interstitial Lung Diseases (ILD)
- NCT03821129 · 636 participants · NA
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia